24.5 C
Vientiane
Wednesday, January 21, 2026
spot_img
Home Blog Page 713

ST Engineering iDirect Powers Verizon Frontline’s Infrastructure Upgrade for Emergency Communications

HERNDON, Va., Nov. 3, 2025 /PRNewswire/ — ST Engineering iDirect, a leader in satellite communications, today announced its continued partnership with Verizon Frontline to enhance its emergency response capabilities through a significant infrastructure upgrade.

Verizon is upgrading its network to ST Engineering iDirect’s Intuition infrastructure, featuring DCR/DBR, a virtualized, cloud-native hub architecture.
Verizon is upgrading its network to ST Engineering iDirect’s Intuition infrastructure, featuring DCR/DBR, a virtualized, cloud-native hub architecture.

Verizon is upgrading its network to ST Engineering iDirect’s Intuition infrastructure, featuring DCR/DBR, a virtualized, cloud-native hub architecture. This modernization reduces Verizon’s physical footprint at the teleport and once fully implemented, will enable faster deployment of mission-critical resources while ensuring uninterrupted services during emergencies such as hurricanes, wildfires, and other natural disasters.

“The modernization of our network with the Intuition infrastructure underscores our unwavering commitment to supporting first responders and communities,” said Stuart Burson, Director of Satellite Solutions at Verizon. “This investment ensures we’re always ready to deliver resilient, innovative connectivity solutions precisely when they’re needed most.”

“With the Intuition upgrade, we are enabling Verizon to respond faster and operate more flexibly, aligning their capabilities with real-world disaster recovery needs,” said Darren Ludington, Regional VP Americas at ST Engineering iDirect. “These advancements guarantee reliable communication tools for first responders, ensuring success in any emergency scenario.”

The decade-long partnership between ST Engineering iDirect and Verizon Frontline reflects a shared commitment to innovation and equipping first responders with the tools needed to protect communities.

ST Engineering iDirect, a subsidiary of ST Engineering, is a global leader in satellite communications (satcom) providing technology and solutions that enable its customers to expand their business, differentiate their services and optimize their satcom networks. With over 40 years of delivering innovation focused on solving satellite’s most critical economic and technology challenges we are committed to shaping the future of how the world connects. The product portfolio, branded iDirect, represents the highest standards in performance, efficiency and reliability, making it possible for its customers to deliver the best satcom connectivity experience anywhere in the world. ST Engineering iDirect is a leader in key industries including mobility, broadcast and military/government. In 2007, iDirect Government was formed to better serve the U.S. government and defense communities. For more information visit www.idirect.net.

 

From Lab to Line: W&J Instrument Launches Scalable & Affordable Viscometer Series to Bridge R&D and Production

The new series gives manufacturers in food, energy, and petrochemicals a unified standard for quality, combining lab-grade precision with industrial-scale efficiency.

CHANGZHOU, China, Nov. 3, 2025 /PRNewswire/ — W&J Instrument, a viscometer manufacturer specializing in industrial and laboratory measurement equipment, just launched its latest series of scalable and affordable viscometers. This lineup built to eliminate the costly disconnect between R&D labs and production floors. It’s a direct response to the growing call for reliable viscosity control in sectors like food processing, pharmaceuticals, new energy, coatings, and petrochemicals.

With costs climbing and regulations getting stricter, getting a handle on viscosity has turned into a critical element for keeping products consistent. But plenty of manufacturers hit roadblocks when trying to apply lab findings to large-scale production, since those fancy R&D tools are often too pricey or tricky for everyday factory use. W&J’s new viscometer series steps in to fix that, cutting down on waste and helping teams convert lab discoveries into real-world gains right on the assembly line.

Viscometer Series of W&J
Viscometer Series of W&J

Market Demand Fuels Innovation in Viscosity Measurement

Reports from Future Market Insights show the worldwide viscometer market gearing up for a steady climb of around 5%–7% CAGR up to 2030, thanks to more automation and the push for dependable material quality. Demand is particularly strong in petrochemical fluid analysis, food production, and ink and coating quality control, where accurate viscosity measurement reduces downtime and ensures compliance. Drawing on over 25 years in the game, W&J Instrument is tackling this head-on with OEM-customized viscometer options tailored for specific industry needs.

“We spoke with countless engineers and production managers. The engineers need data they can trust, while the managers need equipment that is reliable, efficient, and fits the budget,” said Eunice, CEO of W&J Instrument. “Our goal was to end the compromises. These viscometers ensure that the innovation happening in the lab doesn’t get lost in translation on its way to the customer.”

Bridging Lab Precision with Line Performance

The core of W&J’s strategy is a unified technology platform across its entire lineup, which includes Brookfield viscometers, lab viscometers, kinematic viscometers, and dial viscometers. This shared architecture means a petrochemical engineer can use a high-precision laboratory viscometer for fluid development and then deploy a system using the same core calibration on the production line for continuous monitoring. The result is a dramatic reduction in cross-instrument variation, saving time and improving throughput.

To create a complete quality workflow, W&J also provides essential calibration and measurement tools, including precision test weights, industrial scales, analytical lab balances, and moisture analyzers. All products are available with OEM customization, allowing customers to build an integrated and traceable measurement system across their entire operation.

Delivering Value Through Affordability and Customization

“Making this level of precision accessible is key,” added Eunice. “We are providing the tools for small and mid-sized manufacturers to compete on a global scale. It comes back to our founding principle: good quality for survival, good faith for development.”

Looking ahead, W&J is developing IoT capabilities for its instruments to provide real-time viscosity data, giving operators the insights needed to further optimize processes for smart manufacturing.

About W&J Instrument

Founded in 1998 in Changzhou, Jiangsu, China, W&J Instrument is a professional manufacturer of electronic balances, moisture analyzers, viscometers, and related laboratory instruments. Operating on a factory footprint exceeding 3,000 square meters and supported by over 500 employees, the company specializes in OEM customization and precision measurement solutions. True to its motto “Good quality for survival, good faith for development,” W&J Instrument keeps supplying accurate, dependable, and easy-to-get measurement equipment to labs and industries around the globe.

Website: www.weighinginstru.com

Contact: 

E-mail:weighinginstru@gmail.com
Tel:+86-(0)519-85286336

Samsung Biologics completes spin-off to strengthen its focus as a pure-play CDMO

  • Spin-off finalized within five months following board resolution
  • Proposal approved in shareholders’ meeting with 99.9% support
  • Company to reaffirm its identity as a pure-play CDMO

INCHEON, South Korea, Nov. 3, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS) today announced the completion of its spin-off of Samsung Bioepis, reinforcing its strategic focus and business specialization as a leading pure-play Contract Development and Manufacturing Organization (CDMO).

Following approval by its Board of Directors, Samsung Biologics separated its investment and subsidiary management business unit to establish Samsung Epis Holdings. The decision was finalized on November 1, with plans to proceed with registration for the corporate division.

The spin-off was successfully completed within five months of its initial announcement. Since disclosing the plan in May, Samsung Biologics submitted its prospectus in August, received regulatory approval in September, and secured shareholder consent at the Extraordinary General Meeting held on October 17.

The spin-off plan was approved with 99.9% shareholder support, reflecting strong confidence in the company’s strategic direction and reaffirming market trust in the rationale behind the separation.

Trading of Samsung Biologics shares has been temporarily paused until November 21 and will resume on November 24, following the re-listing of Samsung Biologics and the new listing of Samsung Epis Holdings.

With the spin-off complete, Samsung Biologics will accelerate its growth as a pure-play CDMO, anchored on three strategic pillars: expanding production capacity, diversifying its service portfolio, and strengthening its global footprint.

By 2032, the company plans to complete construction of its second Bio Campus, further reinforcing its position as the world’s largest biomanufacturer with a total capacity of 1,324,000 liters. It also aims to broaden its portfolio to include next-generation modalities such as antibody-drug conjugates (ADCs) and organoids.

Currently serving 17 of the world’s top 20 global pharmaceutical companies, Samsung Biologics also plans to extend its reach to the top 40 global biopharma clients, with additional expansion into Japan and the broader Asia-Pacific region.

“Through this spin-off, we have solidified our position as a pure-play CDMO and established a firm foundation for continued global growth,” said John Rim, President and CEO of Samsung Biologics. “We remain committed to strengthening operational excellence and creating enduring value for our clients and the patients they serve.”

About Samsung Biologics

Samsung Biologics (KRX: 207940.KS) is a leading contract development and manufacturing organization (CDMO), offering end-to-end integrated services that range from late discovery to commercial manufacturing.

With a combined biomanufacturing capacity of 784,000 liters across five plants, Samsung Biologics leverages cutting-edge technologies and expertise to advance diverse modalities, including multispecific antibodies, fusion proteins, antibody-drug conjugates, and mRNA therapeutics.

By implementing the ExellenS™ framework across its manufacturing network with standardized designs, unified processes, and advanced digitalization, Samsung Biologics ensures plant equivalency and speed for manufacturing continuity.

Samsung Biologics also operates commercial offices in Korea, the U.S., and Japan. Samsung Biologics America supports clients based in the U.S. and Europe, while its Tokyo sales office serves the APAC region.

Samsung Biologics continues to invest in new capabilities to maximize operational and quality excellence, ensuring flexibility and agility for clients. The company is committed to the on-time, in-full delivery of safe, high-quality biomedicines, as well as to making sustainable business decisions for the betterment of society and global health.

For more information, visit https://samsungbiologics.com/

Samsung Biologics Media Contact
Claire Kim, Head of Marketing & Global Communications
cair.kim@samsung.com

Ping An Rewarded MSCI AAA ESG Rating, Setting the Insurance Industry Benchmark in Asia-Pacific for Four Year Running

HONG KONG and SHANGHAI, Nov. 3, 2025 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (“Ping An” or “the Group”, HKEX: 2318/82318; SSE: 601318) has been upgraded to the highest global ESG rating of AAA for 2025 by MSCI, a leading provider of critical decision support tools and services for the global investment community. This achievement reflects Ping An’s exceptional performance in responsible investment, green finance, and sustainable development, enabling the Group to maintain its leading position in the Asia-Pacific region’s “Multi-Line Insurance & Brokerage Industry” for four consecutive years. The rating underscores Ping An’s continued leadership and commitment within the global ESG landscape.

According to the MSCI rating report, Ping An leads the industry in six key areas: Human Capital Development, Privacy & Data Security, Access to Finance, Financing Environmental Impact, Responsible Investment, and Corporate Behavior.

Leveraging Integrated Financial Strengths to Expand Inclusive Financial Services

In 2025, Ping An introduced the “Policy Statement on Financial Inclusion (2025)“, reaffirming its commitment to utilizing its comprehensive financial platform to enhance both the accessibility and quality of inclusive financial services. By the end of June 2025, Ping An Bank supported 972,900 micro and small enterprise loan customers, with the outstanding balance of inclusive loans reaching RMB 499.524 billion. During the first half of 2025, Ping An Property & Casualty delivered RMB 189 billion in risk protection to 1.61 million micro and small enterprises, providing robust support for social welfare.

Advancing Green Finance Initiatives to Drive Low-Carbon Industrial Transformation

Ping An approaches green finance as a comprehensive, systematic endeavor, leveraging insurance, credit, and investment to facilitate green development and support the transition to low-carbon industries. By the end of June 2025, Ping An’s insurance fund allocated to green investments reached RMB 144.482 billion, while green loan balances amounted to RMB 251.746 billion. Ping An’s green insurance premium income amounted to RMB 55.279 billion in the first nine months of 2025, actively supporting China’s objectives of achieving “peak carbon” emission by 2030 and “carbon neutral” by 2060.

Integrating ESG Factors into Investment Processes and Ongoing Policy Enhancement

As the first domestic asset owner to sign the UN Principles for Responsible Investment (PRI), Ping An has comprehensively incorporated ESG factors into the entire investment decision-making process of its insurance funds. In 2025, the Group updated its “Policy Statement on Responsible Investment of Ping An Group (2025)” further refining exclusion lists and exit mechanisms, enhancing information disclosure and stakeholder communication, and continuously strengthening its responsible investment capabilities. By the end of June 2025, Ping An’s responsible investment of insurance fund reached RMB 1,017.407 billion, including RMB 144.482 billion in green investments, RMB 858.085 billion in social investments, and RMB 14.84 billion in inclusive investments.

Enhancing Information Security Management and Safeguarding Customer Data Privacy

In 2025, Ping An revised its “Policy Statement on Information Security (2025)” and “Policy Statement on Privacy Protection (2025)“, further strengthening its systems for protecting customer privacy and information security. In 2024, the Group and its member companies conducted 67 security emergency drills, covering 11 emergency scenarios, such as ransomware incidents, anti-DDoS (distributed denial-of-service) attacks and phishing emails. It carried out database backup recovery drills and cross-regional joint disaster recovery exercises. These initiatives have significantly improved the organization’s emergency response capabilities for information security.

Commitment to Employee Development, Diversity, Inclusion, and Health & Safety

Ping An is dedicated to fostering employee growth and professional advancement. In 2024, the Group invested RMB 956 million in training initiatives, resulting in an average of more than 49 training hours per employee. In 2025, Ping An issued the “Policy Statement on Occupational Health and Safety (2025)” and updated the “Statement on Employee Rights (2025)” , reaffirming its commitment to diversity, equity, inclusion, and the well-being of its workforce. By the end of 2024, female represented 51% of Ping An’s employees and 36% of senior management, underscoring the Group’s progress in promoting gender equality and cultivating a diverse leadership team.

Sustained Leadership in Sustainable Development and Building a Resilient Financial Ecosystem

In addition to the Group’s overall rating upgrade, its member companies – Ping An Good Doctor, Ping An Bank, and Lufax have each attained AA MSCI ESG ratings, underscoring their exceptional performance in sustainable development across various business segments.

Sustainable development remains a core, long-term strategy for Ping An and serves as the foundation for maximizing enduring value. As a leader in China’s ESG landscape, Ping An is dedicated to embedding sustainability within its corporate strategy, establishing a rigorous and professional ESG management system, maintaining a transparent governance framework, and implementing ESG principles across all areas of operation. Moving forward, Ping An will continue to deepen its technology-enabled “integrated finance + health and senior care” dual-pronged strategy, to create stable, and sustainable value for customers, employees, shareholders, and society, while fostering a more resilient, inclusive, and efficient sustainable financial ecosystem.

About Ping An Insurance (Group) Company of China, Ltd.

Ping An Insurance (Group) Company of China, Ltd. (HKEX:2318 / 82318; SSE:601318) is one of the largest financial services companies in the world. It strives to become a world-leading provider of integrated finance, health and senior care services. Under the technology-enabled “integrated finance + health and senior care” dual-pronged strategy, the Group provides professional “financial advisory, family doctor, and senior care concierge” services to its nearly 250 million retail customers. Ping An advances intelligent digital transformation and employs technologies to improve financial businesses’ quality and efficiency and enhance risk management. The Group is listed on the stock exchanges in Hong Kong and Shanghai. As of the end of December 2024, Ping An had more than RMB12 trillion in total assets. The Group ranked 27th in the Forbes Global 2000 list in 2025, 47th in the Fortune Global 500 list in 2025, and ranked AAA in MSCI ESG Ratings in 2025

For more information, please visit the www.group.pingan.com and follow our LinkedIn page – PING AN.

China Automotive Systems Signs Strategic Cooperation MoU With KYB-UMW to Advance High-End Manufacturing in Malaysia and Further Develop ASEAN Market

WUHAN, China, Nov. 3, 2025 /PRNewswire/ — China Automotive Systems, Inc. (NASDAQ: CAAS) (“CAAS” or the “Company”), a leading power steering components and systems supplier in China, today announced that its  subsidiary, Hubei Henglong Automotive Systems Group Co., Ltd. (“Hubei Henglong”), has signed a strategic cooperation memorandum of understanding (“MoU” ) with KYB-UMW Sdn Bhd in Malaysia.

KYB-UMW is a well-known local supplier of automotive chassis systems. It is a joint venture between KYB, a globally renowned automotive shock absorber and component company, and UMW, a core Malaysian automotive enterprise. UMW is a Malaysian conglomerate with core businesses covering automobiles, engineering, energy and other fields. It holds a 38% stake in Perodua, Malaysia’s largest car manufacturer, and it has also established a joint venture with Toyota in Malaysia, UMW Toyota Motor, providing significant influence in the local automotive industry chain.

This collaboration transcends a simple product export model, achieving a deep partnership encompassing technology transfer, collaborative production, and joint future planning. Initially, products will be supplied to Perodua, Malaysia’s national automotive brand. Moving forward, both parties will jointly explore further opportunities in the OEM and aftermarket sectors, extending the benefits of their collaboration to the broader ASEAN region. Through the cooperation MoU, a regional manufacturing and supply system will be centered in Malaysia, providing high-quality steering system solutions for original equipment manufacturers (OEMs) and the replacement parts market (REM).

According to the MoU, the two parties will jointly produce key automotive components such as electric power steering (EPS) systems and mechanical steering gears (MSG) locally. This cooperation represents an overseas extension of Hubei Henglong’s advanced technological capabilities and is also an important step to achieve localized manufacturing and regionalized services. The advanced technology brought by Hubei Henglong is expected to enhance KYB-UMW’s competitiveness as an automotive systems supplier.

To support this strategic partnership, KYB-UMW’s new advanced manufacturing plant (SP25) under construction is expected to be completed in December 2025 and operational in 2026. This plant will be dedicated to producing steering system products, including those using Hubei Henglong technology. Through cooperation with KYB-UMW, Hubei Henglong will introduce advanced Chinese steering technology to Malaysia, and work with local partners to build a future-oriented smart manufacturing ecosystem. This MoU marks a shift in Sino-Malaysian manufacturing cooperation from “supply chain reciprocity” to “value chain co-creation”.

In August 2018, Hubei Henglong and KYB formed Henglong KYB, which engages in design, manufacture, sales and after-sales service of automobile electronic systems, particularly for various advanced electric power steering (“EPS”) systems. This new cooperation further strengthens this ongoing relationship and expands its presence in the ASEAN markets.

Mr. Qizhou Wu, the Chief Executive Officer of CAAS, commented, “This strategic cooperative MoU marks a key step forward for Hubei Henglong in its internationalization strategy and regional cooperation.  With our partners, we plan to bring advanced steering system technology into the Malaysian and ASEAN markets as a key component of Hubei Henglong’s regional growth strategy. We firmly believe that by combining Hubei Henglong’s deep R&D expertise and product quality in advanced steering technology with KYB-UMW’s strong local manufacturing capabilities and market influence in Malaysia, we can efficiently and quickly provide local customers with high-quality, highly competitive steering system products and services.”

“Moving forward, both parties will jointly explore further opportunities in the OEM and aftermarket sectors, extending the benefits of their collaboration to the broader ASEAN region. We believe the ASEAN market is offering great growth opportunities for localized automotive parts manufacturing. We look forward to working closely to achieve localized production of high-value components at the Serendah campus. This is  a win-win situation for both companies, and a significant step in driving the transformation of Malaysia’s automotive industry,” Mr. Wu concluded.

About China Automotive Systems, Inc.

Based in Hubei Province, the People’s Republic of China, China Automotive Systems, Inc. is a leading supplier of power steering components and systems to the Chinese automotive industry, operating through its sixteen Sino-foreign joint ventures and wholly owned subsidiaries. The Company offers a full range of steering system parts for passenger automobiles and commercial vehicles. The Company currently offers four separate series of power steering with an annual production capacity of over 8 million sets of steering gears, columns and steering hoses. Its customer base is comprised of leading auto manufacturers, such as China FAW Group, Corp., Dongfeng Auto Group Co., Ltd., BYD Auto Company Limited, Beiqi Foton Motor Co., Ltd. and Chery Automobile Co., Ltd. in China, and Stellantis N.V. and Ford Motor Company in North America. For more information, please visit: http://www.caasauto.com

Forward-Looking Statements

This press release contains statements that are “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. Forward-looking statements represent our estimates and assumptions only as of the date of this press release. Our actual results may differ materially from the results described in or anticipated by our forward-looking statements due to certain risks and uncertainties. As a result, the Company’s actual results could differ materially from those contained in these forward-looking statements due to a number of factors, including those described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission on March 28, 2025, and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. Any of these factors and other factors beyond our control, could have an adverse effect on the overall business environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict, and materially and adversely impact our business, financial condition and results of operations. A prolonged disruption or any further unforeseen delay in our operations of the manufacturing, delivery and assembly process within any of our production facilities could continue to result in delays in the shipment of products to our customers, increased costs and reduced revenue. We expressly disclaim any duty to provide updates to any forward-looking statements made in this press release, whether as a result of new information, future events or otherwise.

For further information, please contact:

Jie Li
Chief Financial Officer
China Automotive Systems, Inc.
jieli@chl.com.cn 

Kevin Theiss
Awaken Advisors
+1-212-510-8922
Kevin@awakenlab.com 

Inside “Beautiful Nightmare”: When BXG Turned Halloween into a Luxury Fantasy with VIP EXTRA

Where beauty met the forbidden, and the night remembered every name.

  • The Night That Redefined Halloween

MACAU SAR – Media OutReach Newswire – 3 November 2025 – Halloween in Asia had never looked this extraordinary. On October 30, 2025, BXG (Beauty Express Group), the creative powerhouse behind leading beauty brands including Telosin, A80 Paris, The Mineral Boutique, Apeiro, and 24 Auro, unveiled “Beautiful Nightmare”, an electrifying Halloween experience brought to life through its flagship luxury platform, VIP EXTRA.

Image 1

It wasn’t just a celebration; it was the most extreme Halloween event in Asia, where beauty met desire and every moment shimmered with fearless creativity.

More than 500 very lucky guests from Hong Kong, Singapore, the Philippines, China, Thailand, Indonesia and Europe gathered in Macau to witness a night of surreal glamour and indulgence. Among them were over 100 celebrities, influencers, and tastemakers, all part of a spectacle that redefined what luxury nightlife could be.

Image 2

The Prelude: Beauty Before the Darkness

The evening began inside a lavish W Hotel Macau suite, transformed into a high-glamour pre-party sanctuary.DJ Ornusa Cadness delivered a captivating set for over 100 top KOLs and influencers gathered for a night of anticipation and transformation.

Here, VIP EXTRA guests indulged in exclusive glow-up experiences, with A80 Paris offering bespoke hair styling, and Telosin, Apeiro, and The Mineral Boutique (TMB) delivering radiant skincare and beauty rituals. Each guest received personalized beauty gifts, turning preparation into performance, a moment of transformation before stepping into the night’s seductive chaos.

image 3

The Descent: A Dream in the Dark

As the clock struck nine, the energy shifted. Guests descended to MOP, Macau’s hottest club, reborn as a darkly decadent world where high fashion collided with the surreal.

The bassline pulsed through mirrored walls; crystal glasses clinked as sequined silhouettes shimmered beneath crimson light. Champagne flowed like water, while a curated selection of gourmet dishes from renowned chefs kept guests indulged throughout the night. The venue itself became an immersive fantasy — adorned with haunting Halloween décor, glowing LED installations, and bursts of pyrotechnics that lit the room in flashes of gold and scarlet.

Icons from across Asia, including Gaile Lok, Alex Lam, Angie Ng, Utah Lee, Terra Yeung, Tom Price, Vivian Siu, Inky Leong, and many more, filled the space with untamed energy and couture expression.

An international lineup of music DJ providers — LordBS, Ruby, Samir, and Lilium — powered the night with electrifying beats that kept the crowd dancing until dawn. Their soundscapes transformed MOP into a world of rhythm, mystery, and movement.

It was a world where beauty turned wild, a living dream curated through BXG’s unmatched creative direction.

Image 4

Behind the Magic

Curated and produced by BXG, “Beautiful Nightmare” embodied the group’s vision of merging beauty innovation, cultural storytelling, and immersive brand experience. Through VIP EXTRA, BXG continues to set the benchmark for luxury engagement, where members are not just guests but protagonists in an evolving narrative of style.

“It was more than a party. It was an experience that blended creativity, style, and beauty in the most unexpected way,” said Kimmy Lee, Chief Commercial Officer at BXG. “From the W Hotel suite to the MOP dance floor, every moment embodied the VIP EXTRA spirit, bold, beautiful, and unforgettable.”

For BXG, “Beautiful Nightmare” was more than spectacle. It was the embodiment of its belief that beauty becomes unforgettable when it dares to provoke.

Image 5

The Afterglow

With over 150,000 active members across China, Hong Kong, Macau, and beyond, VIP EXTRA, powered by BXG, continues to set new benchmarks for luxury engagement in Asia.

“Beautiful Nightmare” became more than an event; it became a story, a fearless celebration of artistry, glamour, and imagination that left Macau glowing long after the last song ended.

Every VVIP left calling it “the best Halloween party ever”, a night that transformed the meaning of beauty and boldness in the region. Some nights don’t end; they transform

www.vipextra.com
https://www.instagram.com/vipextra_club/?hl=en

www.bexgrp.com

https://www.instagram.com/beautyexpressgroup/?hl=en

Hashtag: #BXGGroup #VIPEXTRA

The issuer is solely responsible for the content of this announcement.

TCT 2025 | Robot-Assisted PCI Enters a New Era: Results of the PANVIS STAR Multicenter Randomized Controlled Trial

SHANGHAI, Nov. 3, 2025 /PRNewswire/ — The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the morning of October 28th (local time), during the “Innovation Session: Robotics and AI-Enhanced Interventions,” Dr. Wang Rui, representing the team of Academician Ge Junbo from Zhongshan Hospital Affiliated to Fudan University, presented to the world for the first time the safety and efficacy data from the multicenter randomized controlled trial of China’s independently developed PANVIS STAR Vascular Interventional Surgery Control System. The results were encouraging ——in the field of Percutaneous Coronary Intervention (PCI), the introduction of robotic technology is gradually transforming traditional surgical paradigms.

PANVIS STAR Trial Data Shows Safety and Efficacy in PCI
PANVIS STAR Trial Data Shows Safety and Efficacy in PCI

I. Research Background: Why Robot-Assisted PCI?

In traditional PCI procedures, vascular interventional physicians must wear heavy lead aprons and operate for extended periods under X-ray , facing multiple occupational risks such as an increased incidence of orthopedic and ophthalmic diseases. With the advancement of precision medicine and telemedicine, robot-assisted PCI has become a key pathway to address these challenges. However, most current interventional robots rely on joystick control, making it difficult to simulate physicians’ techniques and operating habits. Additionally, limited compatible instruments restrict their widespread clinical adoption. The emergence of the PANVIS STAR system aims to break through this bottleneck.

II. PANVIS STAR System: Design Innovations and Functional Highlights

Independently developed by Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. (abrobo) , the PANVIS STAR system boasts the following outstanding features:

  • Equipped with a globally unique PANVIS COF (Catheter On Finger) intuitive operating system: The controller mimics manual operation, aligning better with physicians’ traditional operating habits and reducing the learning curve.
  • Separate sterile cassette design: Supports operation of dual guidewires, dual rapid-exchange devices, and microcatheters, enhancing procedural flexibility.
  • Multiple control motion modes: Improves the system’s flexibility and adaptability, suitable for different vascular environments and various operators’ surgical habits.
  • Ultra-long travel design: Supports the entire procedural workflow after catheter sheath insertion, possessing pan-vascular compatibility.
  • 5G remote operation support: Lays the foundation for performing long-distance remote PCI.

III. CAPTAIN-C Study Design: A Rigorous Multicenter RCT

This prospective, multicenter, randomized controlled trial, led by Principal Investigator Academician Ge Junbo, aimed to evaluate the safety and efficacy of PANVIS STAR in PCI.
Inclusion criteria: Obstructive coronary artery disease, coronary artery stenosis ≥50%, with clinical indication for a single PCI procedure.
Exclusion criteria: Included recent stroke, acute MI within 48 hours, severe comorbidities, and complex coronary anatomy, among others.
The primary endpoint was clinical procedural success, defined as: final TIMI flow grade 3; residual stenosis <30%; and no Major Adverse Cardiovascular Events (MACE) during hospitalization.

IV. Core Results: Safe, Feasible, and Remarkably Effective

The study results showed:
Robotic group: 71 cases; Conventional manual group: 73 cases. There were no significant differences between the two groups in age, gender, underlying diseases (hypertension, hyperlipidemia, diabetes), or clinical diagnosis at admission.
Interventional process and angiographic characteristics: Lesion type, rate of subtotal occlusion lesions, lesion length, and stent length showed no significant differences between groups. Almost all interventions were performed via the transradial approach.
The selected lesions were relatively complex, with B2 and C type lesions exceeding 60% in both groups, and approximately 20% of patients in both groups had subacute STEMI and NSTEMI.

Safety and Efficacy Results:
Clinical success rate: 97.18% in the robotic group.
Robotic technical success: 100%, with no conversions to manual procedure and no device deficiencies.
Remarkable effect in reducing radiation exposure for the primary operator: 97.2% reduction in iatrogenic radiation.
No significant differences were observed between the two groups regarding patient radiation dose and contrast agent volume.
These data not only validate the operational stability of PANVIS STAR in complex coronary lesions but also demonstrate its clear value in reducing physicians’ occupational risks.

V. Innovation and Breakthrough: From “Operable” to “Well-Operable”

The breakthrough of PANVIS STAR lies not only in the technology itself but also in its human-centric ergonomic design philosophy. Its controller simulates the traditional vascular interventional operation mode and techniques, allowing physicians to achieve precise, stable, and remote operation without changing their established habits.

Furthermore, the system supports remote intervention in a 5G environment. A successful remote PCI procedure over a distance of 5,200 kilometers was performed jointly by the team of Academician Ge Junbo and Professor Shen Li from Zhongshan Hospital, Fudan University, along with the team of Director Chen Qingxing (an expert from Zhongshan Hospital assisting in Xinjiang), Director Abulimiti Jamali, and Director Maimaitiaili Tuerxun from Kashi Second People’s Hospital in Xinjiang. This lays a practical foundation for future “cross-hospital,” “cross-regional,” and even “cross-border” PCI surgeries

VI. Clinical Value and Future Prospects

The clinical success of PANVIS STAR signifies that China possesses the capability for independent R&D and clinical translation in the field of interventional robotics. Its pan-vascular compatibility further expands its application prospects in areas such as neurovascular and peripheral vascular interventions.

With the integration of 5G networks and artificial intelligence technologies, future robot-assisted interventions will no longer be limited to “replacing human hands” but will advance towards new stages featuring intelligent navigation, automatic planning, and remote collaboration.

VII. Opening a New Chapter in Precision Intervention

The CAPTAIN-C study is not just a “coming-of-age ceremony” for the PANVIS STAR system; it is a solid step forward for Chinese interventional cardiology in the direction of intelligent and remote procedures. As Academician Ge Junbo’s team stated: “What we pursue is not only technological leadership but also enabling more physicians to perform each procedure safely and efficiently, allowing more patients to benefit from the warmth of technology.”

Media Contact:
Yoyo Wang,
wangluyao@abrobo.com  

 

 

Cango Inc. Announces October 2025 Bitcoin Production and Mining Operations Update

HONG KONG, Nov. 3, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”) today published its Bitcoin production and mining operations update for October 2025.

Bitcoin Mining Production and Mining Operations Update for October 2025

Metric

October 2025 1

September 2025 1

Number of Bitcoin produced

602.6

616.6

Average number of Bitcoin produced per day

19.44

20.55

Total number of Bitcoin held 2

6412.6

5,810.0

Deployed hashrate

50 EH/s

50 EH/s

Average operating hashrate 3

46.09  EH/s

 44.85 EH/s

1.       Unaudited, estimated.

2.       As of month-end.

3.       Average over the month.

Note: Cango holds Bitcoin for the long term and does not currently intend to sell any of its Bitcoin holdings.

 

Paul Yu, CEO and Director of Cango, commented, “In October, we increased our average operating hashrate to over 90%, while our Bitcoin holdings surpassed the 6,000 BTC milestone, reaching a total of just over 6,400 BTC by month-end. These achievements highlight the operational maturity we have attained as we near the one-year mark of our strategic transformation. In October, we announced the termination of our ADR program and the planned direct listing of our ordinary shares on the NYSE, which we expect to complete in November. This further reinforces our commitment to operating as a U.S.-centric organization. We believe these operational and financial milestones put us in a strong position to capture value from emerging opportunities in energy and AI going forward.”

About Cango Inc.

Cango Inc. (NYSE: CANG) is primarily engaged in the Bitcoin mining business, with operations strategically deployed across North America, the Middle East, South America, and East Africa. The Company entered the crypto asset space in November 2024, driven by advancements in blockchain technology, the growing adoption of digital assets, and its commitment to diversifying its business portfolio. In parallel, Cango continues to operate an online international used car export business through AutoCango.com, making it easier for global customers to access high-quality vehicle inventory from China. For more information, please visit: www.cangoonline.com.

Investor Relations Contact

Juliet YE, Head of Communications
Cango Inc.
Email: ir@cangoonline.com 

Christensen Advisory
Tel: +852 2117 0861
Email: cango@christensencomms.com